De Gregorio, Danilo
Inserra, Antonio
Enns, Justine P.
Markopoulos, Athanasios
Pileggi, Michael
El Rahimy, Youssef
Lopez-Canul, Martha
Comai, Stefano http://orcid.org/0000-0002-5686-7194
Gobbi, Gabriella http://orcid.org/0000-0003-4124-9825
Article History
Received: 22 September 2021
Revised: 21 February 2022
Accepted: 22 February 2022
First Online: 17 March 2022
Competing interests
: DDG is a consultant at Diamond Therapeutics Inc, Toronto, ON, Canada. GG and DDG are inventors of a pending patent regarding the use of LSD. DDG was a recipient of Fond Recherche Québec-Santé (FRQS) and a Canadian Institutes for Health Research (CIHR) postdoctoral fellowships. AI is a recipient of a CIHR, FRQS and a Quebec Autism Research Training Program (QART) postdoctoral fellowships. ML-C was a recipient of a Faculty of Medicine of McGill University/Ferring postdoctoral fellowship. The other authors declare no competing interests.